Zhejiang Cancer Hospital

🇨🇳China
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.zchospital.com
Clinical Trials
Related News

Individualized Pharmaceutical-care for Inpatients With Cancer Pain

Not Applicable
Conditions
Cancer Pain
Interventions
Other: pharmaceutical care
First Posted Date
2018-03-06
Last Posted Date
2019-01-15
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
500
Registration Number
NCT03455023
Locations
🇨🇳

Zhejiang cancer hospital, Hangzhou, Zhejiang, China

Individualized Pharmaceutical-care in Outpatients With Cancer Pain

Not Applicable
Conditions
Cancer Pain
Interventions
Other: Pharmaceutical care
First Posted Date
2018-02-20
Last Posted Date
2019-01-15
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
200
Registration Number
NCT03439904
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Hippocampus Avoidance During Intensity Modulated Radiotherapy for T4 Nasopharyngeal Carcinoma Patients

First Posted Date
2018-01-26
Last Posted Date
2018-01-26
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
100
Registration Number
NCT03411954
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Different Radiation Dose of Neoadjuvant Chemoradiation for Resectable Thoracic Esophageal Squamous Carcinoma

First Posted Date
2017-12-22
Last Posted Date
2024-11-18
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
147
Registration Number
NCT03381651
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Remifemin Preventing the Climacteric Symptoms in Breast Cancer

Phase 2
Completed
Conditions
Effect of Drugs
Safety Issues
Interventions
Drug: Remifemin
First Posted Date
2017-11-13
Last Posted Date
2018-07-06
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
85
Registration Number
NCT03339882
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

DEB-TACE Treatment in 367 Liver Cancer Patients

Completed
Conditions
Liver Cancer
First Posted Date
2017-10-23
Last Posted Date
2017-10-23
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
367
Registration Number
NCT03317483

A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer

First Posted Date
2017-09-12
Last Posted Date
2019-06-04
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
388
Registration Number
NCT03280134
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Phase 1
Conditions
Gastric Cancer
Interventions
Drug: Apatinib plus S-1
First Posted Date
2017-09-08
Last Posted Date
2017-09-08
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
12
Registration Number
NCT03276156
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Phase 2
Conditions
Nasopharyngeal Carcinoma
Interventions
Drug: Apatinib
First Posted Date
2017-07-11
Last Posted Date
2017-07-11
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
51
Registration Number
NCT03213587
Locations
🇨🇳

Xiaozhong Chen, Hangzhou, Zhejiang, China

Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen at Least 2nd Line in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer

First Posted Date
2017-07-02
Last Posted Date
2017-07-02
Lead Sponsor
Zhejiang Cancer Hospital
Target Recruit Count
132
Registration Number
NCT03204734
Locations
🇨🇳

Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy